Publications from PsA Program, University of Toronto [PSA newsletter]

1. Gladman DD, Keystone EC, Russell ML, Schachter RK: Impaired antigen specific suppressor cell activity in psoriasis and psoriatic arthritis. J Invest Dermatol 77:406-409, 1981.

2. Gladman DD, Keystone EC, Schachter RK: Aberrations in T lymphocyte subpopulations in psoriasis and psoriatic arthritis. J Invest Dermatol 80:286-290, 1983.

3. Gladman DD, Anhorn KA: HLA Antigens in rheumatoid arthritis - A Canadian experience. J Rheumatol 13:274-276, 1986.

4. Gladman DD, Anhorn KB, Schachter RK, Mervart H: HLA antigens in psoriatic arthritis. J Rheumatol 13:586-592, 1986.

5. Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK: Psoriatic arthritis - clinical and laboratory analysis of 220 patients. Quart J Med 62:127-141, 1987.

6. Hanly J, Russell ML, Gladman DD: Psoriatic spondyloarthropathy: A long term prospective study. Ann Rheum Dis 47:386-393, 1988.

7. Klinkhoff AV, Gertner E, Chalmers A, Gladman DD, Stewart WD, Schachter DG, Schachter RK: Pilot study of etretinate in psoriatic arthritis. J Rheumatol 16:789-791, 1989.

8. Buskila D, Gladman DD: Atlanto-axial subluxation in a patient with psoriatic arthritis. Arthritis Rheum 32:1338-1339, 1989.

9. Hamilton ML, Gladman DD, Shore A, Laxer RM, Silverman ED: Juvenile Psoriatic Arthritis (JPsA) and HLA antigens. Ann Rheum Dis 49:694-697, 1990.

10. Gladman DD, Stafford-Brady F, Chang CH, Lewandowski K, Russell ML: Longitudinal study of clinical and radiological progression in psoriatic arthritis. J. Rheumatol 17:809-812, 1990.

11. Gladman DD, Farewell V, Buskila D, Goodman R, Hamilton L, Langevitz P, Thorne JC: Reliability of measurements of active and damaged joints in psoriatic arthritis. J Rheumatol 17:62-64, 1990.

12. Langevitz P, Buskila D, Gladman D: Psoriatic arthritis precipitated by physical trauma. J Rheumatol 17:695-697, 1990.

13. Buskila D, Langevitz P, Gladman DD: Psoriatic arthritis. J Isr. Med Assoc. (Harefuah) 121:322-5, 1991.

14. Brubacher B, Gladman DD, Buskila D, Langevitz P, Farewell VT: Follow-up in psoriatic arthritis: Relationship to disease characteristics. J Rheumatol 19:917-920, 1992.

15. Buskila D, Langevitz P, Gladman DD, Urowitz S, Smythe H: Patients with rheumatoid arthritis are more tender than those with psoriatic arthritis. J Rheumatol 19:1115-1119, 1992.

16. Gladman DD, Brubacher B, Buskila D, Langevitz P, Farewell VT: Psoriatic spondyloarthropathy in men and women: A clinical, radiographic and HLA study. Clin Invest Med 15:371-375, 1992.

17. Duffy CM, Watanabe Duffy KN, Gladman DD, Brubacher BL, Buskila D, Langevitz P, Farewell V: Utilization of the Arthritis Impact Measurement Scales (AIMS) for patients with psoriatic arthritis. J Rheumatol 19:1727-1732, 1992.

18. Gladman DD, Blake R, Brubacher B, Farewell VT: Chloroquine therapy in psoriatic arthritis. J Rheumatol 19:1724-1726, 1992.

19. Gladman DD, Brubacher B, Buskila D, Langevitz P, Farewell VT: Differences in the expression of spondyloarthropathy: a comparison between ankylosing spondylitis and psoriatic arthritis. Genetic and gender effects. Clin Invest Med 16:1-7, 1993

20. Mader R, Gladman DD, Long J, Gough J, Farewell VT: Does injectable gold retard radiologic evidence of joint damage in psoriatic arthritis. Clinical Investigative Medicine 18:139-143, 1995.

21. Abu-Shakra M, Gladman DD, Thorne JC, Long J, Gough J, Farewell VT: Longterm Methotrexate therapy in Psoriatic Arthritis: Clinical and radiologic outcome. J Rheumatol 22:241-245, 1995.

22. Gladman DD, Farewell VT, Nadeau C: Clinical indicators of progression in psoriatic arthritis (PSA): multivariate relative risk model. J Rheumatol 22:675-679, 1995.

23. Blackmore M, Gladman DD, Husted J, Long J, Farewell VT: Measuring Health Status in Psoriatic Arthritis: The Health Assessment Questionnaire and its modification. J Rheumatol 22:886-893, 1995.

24. Gladman DD, Farewell VT: The role of HLA antigens as indicators of progression in psoriatic arthritis (PSA): multivariate relative risk model. Arthritis Rheum 38:845-850, 1995.

25. Husted J, Gladman DD, Farewell V, Long J: Modified HAQ in psoriatic arthritis. Clin Exp Rheumatol 13:439-444, 1995.

26. Husted J, Gladman DD, Farewell VT, Long J: Validation of the revised and expanded version of the Arthritis Impact Measurement Scales for patients with Psoriatic Arthritis. J Rheumatol 23:1015-1019, 1996.

27. Husted J, Gladman DD, Long JA, Farewell VT: Relationship of the Arthritis Impact Measurements Scales (AIMS) to changes in articular status and functional performance in patients with psoriatic arthritis (PsA). J Rheumatol 23: 1932-1937, 1996.

28. Husted J Gladman DD, Long JA, Farewell VT, Cook R: Validating the SF-36 health questionnaire in patients with Psoriatic Arthritis. J Rheumatol 24:511-517, 1997.

29. Cook RJ, Farewell VT, Gladman DD: Methodology for clinical trials in rheumatology: A logical foundation. J Rheumatol 24:1861-1865, 1997.

30. Wong K, Gladman DD, Husted J, Long J, Farewell VT: Mortality studies in psoriatic arthritis. Results from a single centre. I. Risk and Causes of Death. Arthritis Rheum 40:1868-1872, 1997.

31. Zangger P, Gladman DD, Bogoch ER: Musculoskeletal surgery in psoriatic arthritis. J Rheumatol 25: 725-729, 1998.

32. Gladman DD, Farewell VT, Kopciuk K, Cook RJ: HLA antigens and progression in psoriatic arthritis. J Rheumatol 25:730-733, 1998.

33. Gladman DD, Farewell VT, Husted J, Wong K: Mortality studies in psoriatic arthritis. Results from a single centre. II. Prognostic indicators for mortality. Arthritis Rheum 41:1103-1110, 1998.

34. Rahman P, Gladman DD, Cook RJ, Zhou Y, Young G, Salonen D: Radiological assessment in psoriatic arthritis. Brit J Rheumatol 37:760-765, 1998.

35. Rahman P, Gladman DD, Zhou Y, Cook RJ: The use of sulfasalazine in psoriatic arthritis: a clinic experience. J Rheumatol 25:.1957-1961, 1998.

36. Husted JA, Gladman DD, Cook RJ, Farewell VJ: Responsiveness of health status instruments to changes in articular status and perceived health in patients with psoriatic arthritis (PsA). J Rheumatol 25: 2146-2155,1998.

37. Gladman DD: Clinical Aspects of Spondyloarthropathies. Am J Med Sci 316:234-238, 1998.

38. Gladman DD, Cheung C, Ng CM, Wade JA: HLA C-locus alleles in psoriatic arthritis. Human Immunology 60:259-261, 1999.

39. Gladman DD, Farewell VT: Does early and aggressive treatment improve the prognosis in psoriatic arthritis? Response to comment by Brockbank et al. Arthritis Rheum 42:189, 1999.

40. Rahman P, Gladman DD, Schentag CT: Immunogenetic profile of patients with psoriatic arthritis varies according to the age of onset of psoriasis. Arthritis Rheum 41:822-823,1999.

41. Rahman P, Gladman DD, Schentag C, Petronis A: Excessive paternal transmission in psoriatic arthritis (PsA). Arthritis Rheum 41:1228-1231, 1999.

42. Navsarikar A, Gladman DD, Husted JA, Cook RJ: Validity assessment of the Disabilities of Arm, Shoulder, and Hand questionnaire (DASH) for patients with psoriatic arthritis (PsA) J Rheumatol 26:2191-2194, 1999.

43. Gladman DD, Farewell VT: Progression in psoriatic arthritis: Role of time varying clinical indicators. J Rheumatol 26:2409-2413, 1999.

44. Rahman P, Schentag CT, Beaton M, Gladman DD: Comparison of clinical and immunogenetic features in familial versus sporadic psoriatic arthritis. Clin Exp Rheumatol 18:7-12, 2000.

45. Rahman P, Gladman DD, Beaton M: Accuracy of self-reported family history in psoriatic arthritis. J Rheumatol 27:824, 2000.

46. Zangger P, Gladman DD, Urowitz MB, Bogoch ER: Outcome of Total Hip Replacement for Avascular Necrosis in SLE. J Rheumatol 27:919-923, 2000.

47. Long JA, Husted JA, Matthews DE, Gladman DD: The relationship between patient satisfaction with health and clinical measures of function and disease status in patients with PsA. J Rheumatol 27:958-966, 2000.

48. Zangger P, Esufali ZH, Gladman DD, Bogoch ER: Type and Outcome of Reconstructive Surgery for Different Patterns of PsA. J Rheumatol 27:967-974, 2000.

49. Husted JA, Cook RJ, Farewell VT, Gladman DD: Methods for assessing responsiveness: A critical review and recommendations. J Clin Epi 53:459-468, 2000.

50. Bruce IN, Schentag C, Gladman DD: Hyperuricemia in psoriatic arthritis (PsA) does not reflect the extent of skin involvement. J Clin Rheumatol 6:6-9, 2000.

51. Husted JA, Gladman DD, Farewell VT, Cook R: Health-related quality of life of patients with psoriatic arthritis: A comparison with patients with rheumatoid arthritis. Arthritis Care and Research 45:151-158, 2001.

52. Rahman P, Nguyen E, Cheung C, Schentag C, Gladman DD: Comparison of radiological severity in psoriatic arthritis and rheumatoid arthritis. J Rheumatol 28:1041-1044, 2001.

53. Gladman DD, Ng Tung Hing E, Schentag CT, Cook R: Remission in psoriatic arthritis. J Rheumatol 28:1045-1048, 2001.

54. Lee JCT, Gladman DD, Schentag CT, Cook RJ: The long-term use of azathioprine in patients with psoriatic arthritis. J Clin Rheumatol 7:160-165, 2001.

55. Gladman DD, Farewell, VT, Rahman P, Schentag CT, Pellet F, Ng CM, Wade JA,: HLA-DRB1*04 alleles in psoriatic arthritis (PsA): comparison with rheumatoid arthritis and healthy controls. Human Immunology 62:1239-1244, 2001.

56. Gu J, Marker-Hermann E, Baeten D, Tsai WC, Gladman D, Xiong M, Deister H, Kuipers JG, Huang F, Song YW, Maksymowych W, Kalsi J, Bannai M, Seta N, Rihl M, Crofford LJ, Veys E, De Keyser F, Yu DTY. A 588-gene microarray analysis of the peripheral blood mononuclear cells of spondyloarthropathy patients. Rheumatology 41 759-766, 2002.

57. Martin MP, Nelson G, Lee J-H, Pellett F, Gao X, Klitz W, Wade J, Wilson M, Trowsdale J, Gladman D, Carrington M: Susceptibility to Psoriatic Arthritis: influence of activating Killer Immunoglobulin-like Receptor genes in the absence of their corresponding HLA ligands. J Immunology 169: 2818-2822, 2002.

58. Khan M, Schentag C, Gladman D: Clinical and radiological changes during psoriatic arthritis disease progression: Working toward classification criteria. J Rheumatol (In press)

59. Gladman DD. Effectiveness of Psoriatic Arthritis Therapies. Seminars Arthritis Rheum (In Press).

Books and invited publications

60. Gladman DD: Immunologic factors in the pathogenesis of psoriatic arthritis. Psoriatic Arthritis. Edited by Gerber LH and Espinoza LR. Grune & Stratton, Orlando FL, 1985:33-44.

61. Gladman DD: Psoriatic Arthritis. Canadian Journal of Dermatology 1990;2:74-79.

62. Gladman DD: Psoriatic arthritis. Focus on Rheumatology 1990;3:3-8.

63. Gladman DD: Lupus - disease and treatment. The Female Patient 1990;4:2-7, 1990.

64. Gladman DD: Psoriatic arthritis - Review. Israel J Med Sci 1990;27:228-233.

65. Gladman DD, Buskila D, Langevitz P: Psoriatic arthritis. Can J Dermatol 1990;2:74-79.

66. Gladman DD, Espinoza LE: Meeting Report - International symposium on psoriatic arthritis. J Rheumatol 1990;19:290-291.

67. Gladman DD: Psoriatic arthritis. Ankylosing spondylitis and spondyloarthropathies. Edited by Kahn M. Spine: state of the art review. Hanley & Belfus, Inc., Philadelphia PA, 1990, 4:637-656.

68. Gladman DD: Psoriatic arthritis. Seronegative spondyloarthropathies. Edited by Arnett F. Curr Opin Rheumatol, 1990;2:577-581.

69. Gladman DD: Psoriatic arthritis. Prognosis in the Rheumatic diseases. Edited by Bellamy N. Kluwer Academic Publishers, London, 1991, pp 153-166.

70. Gladman DD: GI related arthritis and psoriatic arthritis. Seronegative spondyloarthropathies. Edited by Arnett F. Curr Opin Rheumatol, 3:575-580, 1991.

71. Gladman DD: Psoriatic arthritis: recent advances in pathogenesis and treatment. Rheum Dis Clin North Am 18:247-256, 1992.

72. Gladman DD: Psoriatic arthritis. Oxford Textbook of Rheumatology. Edited by Maddison PJ, Isenberg DA, Woo P, Glass DN. Oxford University Press, 1993, pp 691-698.

73. Gladman DD: Toward unravelling the mystery of psoriatic arthritis. Editorial. Arthritis Rheum 1993,36:881-884.

74. Abu-Shakra M, Gladman DD: Management of refractory psoriatic arthritis. Rheumatology Reviews 1993;2:201-206.

75. Abu-Shakra M, Gladman DD: Aetiopathogenesis of psoriatic arthritis. Rheumatology Reviews 1994;3:1-7.

76. Gladman DD: The natural history of psoriatic arthritis. In psoriatic arthritis. Edited by Wright and Helliwell. Baillière's Clinical Rheumatology. International Practice and Research. Baillière's Tindall London, 1994, pp 379-394.

77. Gladman DD: Psoriatic arthropathy. Current Opinion in Orthopaedics 1995;6:4-7.

78. Gladman DD: Psoriatic Arthritis. In Classification and Assessment of Rheumatic Disease: Part 1. Edited by Silman AJ and Symmons DPM. Baillière's Clinical Rheumatology. International Practice and Research. Baillière's Tindall, London, 9:319-329, 1995.

79. Rahman P, Gladman DD: Preventing Disability in Psoriatic arthritis. Contemporary Internal Medicine 1997;9:27-35.

80. Gladman DD: Psoriatic arthritis. In Kelley WN, Harris ED, Ruddy S, Sledge CB (eds): Textbook of Rheumatology, 5th Edition, Philadelphia, W.B. Saunders Co, 1997;Volume II, 999-1005.

81. Gladman DD: Psoriatic arthritis. Oxford Textbook of Rheumatology. Edited by Maddison PJ, Isenberg DA, Woo P, Glass DN. Oxford University Press, 1997; 1071-1085.

82. Gladman DD, Koren G: Second line agents in rheumatic diseases during pregnancy. In Van de Putte, Williams, Van Riel, Furst D (eds). Therapy of Systemic Disorders. Marcel Dekker Inc. New York, 1997; 657-665.

83. Gladman DD: Psoriatic Arthritis. Textbook of Clinical Rheumatology. Edited by Feng. The National Arthritis Foundation, Singapore, 112-123, 1998.

84. Farewell VT, Gladman DD: Rheumatology. In: Encyclopaedia of Biostatistics, Vol. 5, Wiley, Chichester, 1998 pp 3832-3836.

85. Bruce I, Gladman DD: Psoriatic arthritis: Recognition and management. BioDrugs 1998;9:271-278.

86. Gladman DD: Psoriatic arthritis. Spondyloarthropathies. Yu D. (Ed). Rheumatic Disease Clinics of North America 1998;24:829-844.

87. Gladman DD, Urowitz MB: Rheumatic disease in pregnancy. Medical complications during pregnancy. 6th Edition. Edited by Burrow JN, Duffy TD. WB Saunders Co., Philadelphia, 1999, pp 415-438.

88. Gladman DD, Brockbank J: Psoriatic arthritis. Expert Opinion on Investigational Drugs 9:1511-1522, 2000.

89. Gladman DD: Spondyloarthropathy. Education Review Manual in Rheumatology. Lahita, R, Weinstein A.. Castle Connelly, Graduate Medical Publishing II:1-21, 2000

90. Gladman DD: How I Treat Psoriatic Arthritis. Acta Reumatologica Portuguesa 98:12-18, 2000.

91. Rahman P, Paterson AD, Gladman DD: Yet another linkage reported -what does it mean? Editorial. J Rheumatol 2000;27:294-297.

92. Gladman DD, Rahman P: Psoriatic arthritis. In Ruddy S, Harris ED, Sledge CB, Budd RC, Sergent JS (eds) Kelly's Textbook of Rheumatology, 6th edition, Philadelphia, W.B. Saunders Co, 2001:1071-1079.

93. Gladman DD: Histocompatibility antigens. In Tannenbaum H, Russell A (Eds). Mechanisms in Rheumatology. MIR Inc. and Core Health Services Inc. Canada, 2001;7-16.

94. Gladman DD: Psoriatic arthritis. Physician Information and Education Resource (PIER) module. American College of Physicians - American Society of Internal Medicine. http://pier.acponline.org/physicians/diseases/.

95. Gladman DD: Psoriatic Arthritis. Classic Papers in Rheumatology. Eds. Dieppe P, Wollheim FA, Schumacher HR. Martin Dunitz Ltd. London England 2002: 134-147.

96. Brockbank J, Gladman DD: Diagnosis and Management of Psoriatic Arthritis. BioDrugs 2002;62:2447-2457.

97. Gladman DD: Current Concepts in Psoriatic Arthritis. Current Opinion Rheumatology. Inman RI (Ed). 2002 14:361-366.

98. Gladman DD, Farewell VT. HLA Studies in Psoriatic Arthritis: Current situation and future needs. Editorial. J Rheumatol 2003;30:4-6.

99. Gladman DD: Psoriatic arthritis. Oxford Textbook of Rheumatology. 3rd Edition. Edited by Maddison PJ, Isenberg DA, Woo P, Glass DN. Oxford University Press 2003,

100. Gladman DD: Spondyloarthropathy. Education Review Manual in Rheumatology. Lahita, R, Weinstein A.. Castle Connelly, Graduate Medical Publishing (In Press)

101. Gladman DD: Psoriatic Arthritis. Therapy Of Moderate-To-Severe Psoriasis. Weinstein GD, Gottlieb AB (Eds). 2nd Edition. Marcel Dekker, Inc.(In press)

[Top] [PSA newsletter]
Copy right © 2002, 2006 Centre For Prognosis Studies In The Rheumatic Diseases, Univerity Health Network.